IPPOSI Chief Executive presented at the EAPM 2017 Conference in Belfast in the ‘Personalised Medicine and Public Health: Two Sides of the Same Coin?’ session.
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Personalised Medicine Congress (EAPM) - Dr Derick Mitchell - November 2017
1. November 29th, 2017
PATIENTS – SCIENCE – INDUSTRY
1st European Alliance for Personalised Medicine Congress
Derick Mitchell
2. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Heart of the PM Ecosystem?
“Just because a system has
patient data at its core does not
mean it is patient-centric”
Jane Grimson
3. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Linking Personalised Medicine & Public Health
• Making better use of patient data (health, genomic, experience)
• Engaging citizens on discourse on precision health
• Improving Genetic Health Literacy
• Adapting HTA frameworks, Real-World Evidence,
• Tackling information governance, consent, Electronic Health Records
HOW CAN PM CHANGE PUBLIC HEALTH PRACTICE?
4. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Collaborative sensemaking
“We are witnessing the collapse of
expertise and the rise of
collaborative sensemaking”
David Holzmer
5. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Evidence-based patient advocacy
In God We Trust…..…Everyone Else Bring Data!
6. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
IPPOSI? Who?IPPOSI
A patient-led organisation
that works with patients,
government, industry,
& science to put patients at
the heart of health innovation
7. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
IPPOSI Priorities + Members
20
Actively advocate for improved + equitable
patient access to Health Innovation
Promote meaningful patient involvement in
Health Research and Policy
8. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Patient-led activities
Health Hacks
Workshops
Consultations
Round-tables
Working Groups
Summer Schools
Conferences
Clinical Research
Health Information
Patient Data
Health Economics
Patient Registries
Dynamic Consent
Data Protection
9. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Incorporating the patient voice
• Hierarchical Rhetoric
• ‘Walking the walk’ at the highest possible level
Challenges:
• Decision-makers never want to change their processes
• Patients are not trained in health policy, dialogue
• Many patient orgs are not focused on policy issues
“The perfect is the enemy of the good”
10. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
What do we need to enable use (& re-use) of patient data?
Good
Education
Legal
Frameworks
SOPs
Frameworks of
Engagement
11. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
What we have learned…
• Trustworthiness is vital….
• patients must believe that their data is secure and only used
for the purposes they consented to
• Equally….
• create the situation where patients are the drivers of their
data, ensuring it is utilised to improve their health
12. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
IPPOSI & The European Patients Academy
• EUPATI produces Expert Patients on
Medicines Research & Development
• Provides Training & Education
• Disseminates through national platforms
The project received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composed of financial
contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.
www.eupati.eu
13. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Roles change as a result of EUPATI course
Role Before EUPATI After
Member of patient organisation, not actively involved 17% 2%
Active role in a patient organisation 62% 71%
Leadership role in a patient organisation 62% 71%
Employee of a patient organisation 25% 23%
Volunteer role in a patient organisation 60% 67%
Presenting at conferences, workshops etc. 63% 83%
Advising a pharmaceutical company 13% 44%
Advising a regulatory agency 21% 42%
Advising a reimbursement agency 4% 8%
EUPATI Fellows are increasingly taking leadership roles and are engaging with
pharma, regulators and HTA bodies. Role changes also imply identity shifts
14. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
The Power of Patient Education
7-month programme in Health Innovation
Blended Learning – online + workshops
3 x 6-week modules
• Clinical Trials
• Regulatory Affairs
• Health Technology Assessment
4 x Education Partners - UCD, TCD, HPRA, HIQA
1 elearning website - www.patientsinvolved.ie
21 Students from 9 counties
15. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Frameworks of Engagement
2008 - National Strategy for Service User Involvement in
Health and Social Services (DoHC & HSE)
---------------------------------------------------------------------------
2016 – Values in Action, QID Cultures of Person-centeredness (HSE)
2016 – Mental Health Local Recovery Groups (HSE)
2016 – Privacy Impact Assessment for Individual Health Identifier
(eHealth Ireland)
2017 - National Patient Experience Survey - Hospitals (HIQA, HSE, DoH)
2017 - National Clinical Effectiveness Committee – PPI Values
(DoH, NCEC)
2017 –Personas for Electronic Health Records (eHealth Ireland)
2017/18 - Patient Narrative Project on Person-centered care
(CSPD-HSE, IPPOSI)
16. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
The Patient
Narrative
Project
Reference: Phelan A., Rohde D., Casey M., Fealy G., Felle P., Lloyd H. & O’Kelly G. (2017) Patient
Narrative Project for Person-Centred Co-ordinated Care. UCD, IPPOSI & HSE, Dublin.
Phases 1 + 2 + 3:
Person-centered,
co-ordinated care
17. Person centered co-ordinated care
Phase 1
What people in Ireland want to experience
during their care when they require a
number of health services at one time or
over time
Phase 2 + 3
A framework that will hear peoples’
experiences of using more than one health
service at a time
11 Focus
Groups
2 Online
Surveys
4 Regional
Workshops
Output: Statements (19) + Definition (1)
Online Survey
+ System
Partnerships
18. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Themes Emerging
From Phase 1
My
healthcare
experiences
Healthcare
I am
confident in
My journey
through
healthcare
19. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
My Journey through Healthcare
• My care includes issues that my health influences, such as finances, housing,
employment, ability to travel and access to transport.
• I have services delivered by the most suitable healthcare staff in the correct
setting and when I need them.
• I can have one person who will oversee and follow up on all my care.
21. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Phase 2
• http://www.hse.ie/yourvoicematters
22. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
• Survey remains live
• Proof-of-Concept
• Producing data on patients’ experience of care when they use
more than one health service
• Target:
• 1000 stories nationally, particularly in relation to older people and
people with chronic conditions
• Channel through Integrated Care Programmes HSE
23. By end of 2017… By end of 2018…
A ‘tried and tested’ framework
• To hear a high volume of patients’
experiences through the online
survey
• To use data to influence service
design, delivery and improvement
of integrated care
• A qualitative and quantitative
evaluation of the proof of concept
within the context of the HSE;
Integration into ‘business as usual’
• Framework (incl. resource
implications) to be integrated into a
‘business as usual’ model
• Quality and Patient Safety Structures
at CHO level will be essential
• QID publication: ‘Quality and Safety
Committees; Guidance and resources’
24. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Patient Narratives in PM?
Right treatment, Right time, Right patient
at the right location, by the right provider, at the right cost
Minimally Disruptive Treatments
• Impact on clinical trial design
• Impact on clinical guidelines
• Impact on clinical practice
• Impact on service delivery, coordination
V-T Tran et al. (2015) Taxonomy of the burden of treatment:
a multi-country web-based qualitative study of patients with
chronic conditions BMC Medicine 13:115
25. European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie
Where we want to get to…
INFORM ENGAGE EMPOWER
At the heart of the ecosystem is the empowered patient
We would like to create the situation where patients are the drivers of their data, ensuring it is utilised to improve their health. A patient who, with the right information, could start to gain control of their health.
I encourage you to keep the patient at the centre of this developing ecosystem
Hopefully I can present some ideas on how these two areas can come closer together..
Focus on patient need, inform multidiciplinary care
Last year – experience of patients here
I presented the why, who etc. focus on HTA agencies
This year?
A patient-led platform that provides a structured way of facilitating interaction between patients, government, industry, science and academia to put patients at the heart of policy and medicines development. In pursuit of this we hold workshops, discussion groups, training days and conferences on policy, legislation and regulation around the development of new medicines, products, devices and diagnostics for unmet medical needs.
Regulators and funders are doing it!
Everyone to understand the potential and know how to make the most of it
Context is how do you transform services towards what people want, when they want them.
The Clinical Strategy & Programmes Division of the HSE initiated the Patient Narrative Project to partner with users of healthcare services in the design and delivery of these services.
The Patient Narrative Project is a three phase project to progress to partnership working
listened to the experiences of people who have had to use multiple health services over time or at one time and through the words of the service users and caregivers developed a set of statements that clearly articulate what users of the Irish health service expect from services and staff.
In addition a definition of person-centred co-ordinated care that is written not just for the experts, but for patients, people, families and carers
The goal is that the descriptors + definition of what good care and support that is centred around the needs and preferences of the service user/patient looks and feels like for people will be adopted nationally. They will be used to guide policy, strategy and design, and act as a guide to what teams at local levels should be aiming to achieve practically, in their efforts to integrate services around patient, family and carer needs.
There are three themes of descriptors:
‘Care for me’ focused on the direct relational experience with healthcare professionals.
‘Care I am confident in’ refers to the actual experience of care in terms of skills, quality, accountability and continuity of care.
‘Care in my journey through healthcare’ represents care that is holistic, accessible at a time needed and takes account of the world of the person and their carer beyond what was traditionally considered health care, but where health has an impact (e.g. education, working life)
The Clinical Strategy & Programmes Division of the HSE initiated the Patient Narrative Project to partner with users of healthcare services in the design and delivery of these services.
The Patient Narrative Project is a three phase project to progress to partnership working
IPPOSI, the Irish Platform for Patient Organisations, Science and Industry, led the first phase of the project. A UCD research team led by Dr Amanda Phelan carried out the research study which listened to the experiences of people who have had to use multiple health services over time or at one time and through the words of the service users and caregivers developed a set of statements that clearly articulate what users of the Irish health service expect from services and staff.
In addition a definition of person-centred co-ordinated care that is written not just for the experts, but for patients, people, families and carers
The goal is that the descriptors + definition of what good care and support that is centred around the needs and preferences of the service user/patient looks and feels like for people will be adopted nationally. They will be used to guide policy, strategy and design, and act as a guide to what teams at local levels should be aiming to achieve practically, in their efforts to integrate services around patient, family and carer needs.
There are three themes of descriptors:
‘My care experiences’ focused on the direct relational experience with healthcare professionals.
‘Care I am confident in’ refers to the actual experience of care in terms of skills, quality, accountability and continuity of care.
‘Care in my journey through healthcare’ represents care that is holistic, accessible at a time needed and takes account of the world of the person and their carer beyond what was traditionally considered health care, but where health has an impact (e.g. education, working life)
The experiences of patients, carers, and their organisations were translated into a definition of person-centred co-ordinated care that is written not just for the experts, but for patients, people, families and carers. 19
The goal is that the descriptors + definition of what good integrated care and support looks and feels like for people will be adopted nationally. They will be used to guide policy, strategy and design, and act as a guide to what teams at local levels should be aiming to achieve practically, in their efforts to integrate services around patient, family and carer needs.
‘Care for me’ ‘focused on the direct relational experience with healthcare professionals.
‘Care I can reply on’ ‘refers to the actual experience of care in terms of skills, quality, accountability and continuity of care.
‘Care in my journey through healthcare’ ‘represents care that is holistic, accessible at a time needed and takes account of the world of the person and their carer beyond what was traditionally considered health care, but where health has an impact (e.g. education, working life)
My healthcare experiences: Direct relational experience with healthcare profs
Healthcare I am confident in: Actual experience of care in terms of skills, quality, accountability and continuity of care
My journey through healthcare: Three aspects: holistic care, coordination of care within and across services, and access to services when needed.
The statements and definition indicate that Irish health service users want to be empowered in a seamless journey through the health services, they want to take an active informed role in their care and to be treated as people not health conditions.
In addition they expect staff to live the values of the HSE; care, compassion, trust and learning within the workplace and their interactions
10,000 Voices in NI - 14,000 patients have now completed this survey
40 per county and 20 OP and 20 CC with the additional stories from the populations covered in Social Inclusion.
In addition to the collection of data the project will review the most effective and efficient means of stakeholder engagement in order that this can inform the project and business plan for longer term.
identification of enablers and challenges to successful implementation
CIHR - Stephen Robbins
Usual quote re: Permed: Right treatment, right time, right patient
Add: at the right location, by the right provider, at the right cost.
Greater focus on access & equity
Minimizing disruption to the patient
Negotiating goals
Is stratified medicine really targeting patients unmet needs?
Is the promise a fulfillable one?
If you happen to fit the bill (eligible for a trial), then great, but what about the others still in the dark?
Will PM affect the standard of care if its only for a small cohort?
If the trials are more efficient, we will know much quicker what the benefit will be..
Need confidence that the ‘off you go, flog it’
I’ll let you into a secret – patients are not interested in drugs that don’t work – other stakeholders are interested in keeping the status quo – if they are not working, then you are simply wasting time…so concentrate on the things that do work
Study recently estimated over 50 things which are on the NHS, which have been categorically shown not to work..
Regulators would prefer that biology follows the law, rather than the other way round…
From the patient view, I see the possibility of a life-changing intervention, being snatched away from me..
Ivacaftor is a clear black/white decision
For others, the benefits are less clear.
Its going to be incredibly difficult to organise development programmes to demonstrate the benefit and the value for money for making these available for routine prescription
When you are developing a trial, if you plan your trial based on my life, the things that really affect my life, then I am far more likely to be involved and support.
When someone tells you that patients cannot understand or just do not want to know, just look at the data…..
Our relationship is fragile, dynamic, uncomfortable, ambitious, and goal-oriented
Healthcare Environment is changing….are you?